Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of AG-636 in the Treatment of Subjects With Advanced Lymphoma

NCT03834584 is registered in ClinicalTrials.gov with Agios Pharmaceuticals, Inc. as lead sponsor.

NCT NCT03834584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03834584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of AG-636 in the Treatment of Subjects With Advanced Lymphoma
Lead sponsor
Agios Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
May 24, 2019
Completion date
June 17, 2020
Enrollment
11 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma